Will The Trials Of Bispecific Antibodies Add Shine To F-star Therapeutics?
Bispecific antibodies, which feature two different antigen-binding sites in one molecule, have promising applications in cancer immunotherapy. Only 3 bispecific antibodies have received FDA approval – Janssen Pharma’s Rybrevant to … Read More